ZA943100B - Benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives - Google Patents
Benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivativesInfo
- Publication number
- ZA943100B ZA943100B ZA943100A ZA943100A ZA943100B ZA 943100 B ZA943100 B ZA 943100B ZA 943100 A ZA943100 A ZA 943100A ZA 943100 A ZA943100 A ZA 943100A ZA 943100 B ZA943100 B ZA 943100B
- Authority
- ZA
- South Africa
- Prior art keywords
- benzofuranyl
- thiophenyl
- acid derivatives
- alkanecarboxyclic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939309324A GB9309324D0 (en) | 1993-05-06 | 1993-05-06 | Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA943100B true ZA943100B (en) | 1995-01-09 |
Family
ID=10735023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA943100A ZA943100B (en) | 1993-05-06 | 1994-05-05 | Benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5504213A (xx) |
| EP (1) | EP0623607B1 (xx) |
| JP (1) | JP3452088B2 (xx) |
| CN (1) | CN1097749A (xx) |
| AT (1) | ATE168373T1 (xx) |
| AU (1) | AU678814B2 (xx) |
| CA (1) | CA2122788A1 (xx) |
| CZ (1) | CZ112994A3 (xx) |
| DE (1) | DE69411625T2 (xx) |
| DK (1) | DK0623607T3 (xx) |
| ES (1) | ES2118283T3 (xx) |
| FI (1) | FI942049A (xx) |
| GB (1) | GB9309324D0 (xx) |
| GR (1) | GR3027787T3 (xx) |
| HU (1) | HUT67847A (xx) |
| IL (1) | IL109526A0 (xx) |
| NO (1) | NO941662L (xx) |
| NZ (1) | NZ260445A (xx) |
| RU (1) | RU2125564C1 (xx) |
| SK (1) | SK53194A3 (xx) |
| ZA (1) | ZA943100B (xx) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5721233A (en) * | 1992-04-06 | 1998-02-24 | Merrell Pharmaceuticals Inc. | Derivatives of 2,3-dihydro benzofuranols |
| GB9312853D0 (en) | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
| GB9410877D0 (en) * | 1994-05-31 | 1994-07-20 | Bayer Ag | Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives |
| HRP950288A2 (en) * | 1994-05-31 | 1997-08-31 | Bayer Ag | Oxalylamino-benzofuran- and benzothienyl-derivatives |
| ATE175667T1 (de) * | 1994-05-31 | 1999-01-15 | Bayer Ag | Aminobenzofuryl- und -thienylderivate |
| US5591776A (en) | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
| US5922751A (en) | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
| EP0751126A4 (en) * | 1995-01-06 | 1998-05-13 | Toray Industries | BENZOCONDENSE HETEROCYCLIC DERIVATIVE AND ITS USE |
| GB9504460D0 (en) * | 1995-03-06 | 1995-04-26 | Bayer Ag | N-(3-Benzofuranyl)urea-derivatives |
| US6166041A (en) | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
| US6075016A (en) | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
| CZ371998A3 (cs) * | 1996-05-20 | 1999-03-17 | Darwin Discovery Limited | Benzofuranové karboxamidy a jejich terapeutické použití |
| GB9614718D0 (en) | 1996-07-12 | 1996-09-04 | Bayer Ag | 3-ureido-pyridofurans and -pyridothiophenes |
| DE19642451A1 (de) * | 1996-10-15 | 1998-04-16 | Merck Patent Gmbh | Aminothiophencarbonsäureamide |
| DE19706396A1 (de) * | 1996-12-09 | 1998-06-10 | Bayer Ag | Verfahren zur Herstellung von 3-(l-Hydroxiphenyl-l-alkoximinomethyl)dioxazinen |
| GB2350111A (en) * | 1999-05-17 | 2000-11-22 | Bayer Ag | Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives |
| GB2350109A (en) | 1999-05-17 | 2000-11-22 | Bayer Ag | Pharmaceutically active benzofuranyl sulfonates |
| KR100701904B1 (ko) | 1999-08-21 | 2007-04-02 | 알타나 파마 아게 | Ｐｄｅ 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합 |
| KR100854424B1 (ko) | 2001-01-29 | 2008-08-27 | 3-디멘져널 파마슈티칼즈 인코오포레이티드 | 치환된 인돌 및 인테그린 길항제로서의 이들의 용도 |
| US6872730B2 (en) | 2001-04-27 | 2005-03-29 | 3-Dimensional Pharmaceuticals, Inc. | Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| CA2447618A1 (en) | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | A composition for regenerative treatment of cartilage disease |
| CN1520313A (zh) | 2001-05-23 | 2004-08-11 | ������ҩ��ʽ���� | 一种加速骨折愈合的组合物 |
| US7144885B2 (en) | 2002-02-22 | 2006-12-05 | Bayer Pharmaceuticals Corporation | Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| US7351735B2 (en) * | 2002-02-22 | 2008-04-01 | Bayer Pharmaceuticals Corporation | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| KR20050115331A (ko) | 2003-04-01 | 2005-12-07 | 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. | 불임증 포스포디에스터라제의 억제제 |
| EP1627873A4 (en) * | 2003-05-29 | 2007-12-05 | New Ind Res Organization | BENZOFURAN-BASED COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| JP2005008631A (ja) * | 2003-05-29 | 2005-01-13 | New Industry Research Organization | ベンゾフラン化合物、およびそれを含有してなる医薬組成物 |
| US7576122B2 (en) * | 2003-09-02 | 2009-08-18 | Merck & Co. Inc. | Ophthalmic compositions for treating ocular hypertension |
| AR051780A1 (es) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
| ME00535B (me) * | 2006-06-27 | 2011-10-10 | Takeda Pharmaceuticals Co | Fuzionisana ciklična jedinjenja |
| WO2008025509A1 (en) * | 2006-09-01 | 2008-03-06 | Bayer Schering Pharma Aktiengesellschaft | Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| AU2008261102B2 (en) | 2007-06-04 | 2013-11-28 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| CA2930674A1 (en) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN108676076A (zh) | 2011-03-01 | 2018-10-19 | 辛纳吉制药公司 | 制备鸟苷酸环化酶c激动剂的方法 |
| EP3718557A3 (en) | 2013-02-25 | 2020-10-21 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing |
| JP2016514670A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト |
| CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法 |
| NZ717739A (en) | 2013-08-09 | 2023-12-22 | Ardelyx Inc | Compounds and methods for inhibiting phosphate transport |
| WO2015029062A1 (en) | 2013-08-25 | 2015-03-05 | Council Of Scientific And Industrial Rsearch | A process for the preparation of anti-inflammatory aroylbenzofuran compounds |
| JP6449915B2 (ja) * | 2014-02-25 | 2019-01-09 | エコラボ ユーエスエー インコーポレイティド | 衛生洗剤 |
| CN105254611B (zh) * | 2015-11-09 | 2017-10-31 | 江西仁明医药化工有限公司 | 苯并噻吩‑2‑羧酸的制备方法 |
| CN107935972B (zh) * | 2017-11-14 | 2020-06-02 | 沈阳药科大学 | 5-[2-羟基-3-(异丙胺基)丙氧基]苯并呋喃类衍生物及其应用 |
| CN107857748B (zh) * | 2017-11-14 | 2020-06-02 | 沈阳药科大学 | 5-[2-羟基-3-(烷胺基)丙氧基]苯并呋喃类化合物及其应用 |
| CN107827849B (zh) * | 2017-11-14 | 2020-06-02 | 沈阳药科大学 | 6-[2-羟基-3-(烷胺基)丙氧基]苯并呋喃类化合物及其应用 |
| US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
| CN110938035B (zh) * | 2019-10-28 | 2022-07-01 | 广西师范大学 | 9-苯磺酸-10-咪蒽腙及其合成方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0019955A1 (en) * | 1979-05-16 | 1980-12-10 | Shell Internationale Researchmaatschappij B.V. | Benzofurancarboxylic acid derivatives, their preparation and their inclusion in lipogenesis inhibiting compositions |
| EP0146243A1 (en) * | 1983-10-31 | 1985-06-26 | Merck Frosst Canada Inc. | Lipoxygenase inhibitors |
| US4663347A (en) * | 1983-10-31 | 1987-05-05 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis |
| US4482772A (en) * | 1983-11-03 | 1984-11-13 | Mobil Oil Corporation | Multistage process for converting oxygenates to hydrocarbons |
-
1993
- 1993-05-06 GB GB939309324A patent/GB9309324D0/en active Pending
-
1994
- 1994-04-19 AU AU60558/94A patent/AU678814B2/en not_active Ceased
- 1994-04-22 EP EP94106320A patent/EP0623607B1/en not_active Expired - Lifetime
- 1994-04-22 AT AT94106320T patent/ATE168373T1/de active
- 1994-04-22 ES ES94106320T patent/ES2118283T3/es not_active Expired - Lifetime
- 1994-04-22 DK DK94106320T patent/DK0623607T3/da active
- 1994-04-22 DE DE69411625T patent/DE69411625T2/de not_active Expired - Fee Related
- 1994-04-29 US US08/236,796 patent/US5504213A/en not_active Expired - Fee Related
- 1994-05-02 JP JP11592394A patent/JP3452088B2/ja not_active Expired - Fee Related
- 1994-05-03 IL IL10952694A patent/IL109526A0/xx unknown
- 1994-05-03 CA CA002122788A patent/CA2122788A1/en not_active Abandoned
- 1994-05-03 NZ NZ260445A patent/NZ260445A/en unknown
- 1994-05-04 FI FI942049A patent/FI942049A/fi unknown
- 1994-05-05 NO NO941662A patent/NO941662L/no unknown
- 1994-05-05 ZA ZA943100A patent/ZA943100B/xx unknown
- 1994-05-05 RU RU94015838A patent/RU2125564C1/ru active
- 1994-05-06 HU HU9401415A patent/HUT67847A/hu unknown
- 1994-05-06 SK SK531-94A patent/SK53194A3/sk unknown
- 1994-05-06 CN CN94104909A patent/CN1097749A/zh active Pending
- 1994-05-06 CZ CZ941129A patent/CZ112994A3/cs unknown
-
1998
- 1998-08-31 GR GR980401965T patent/GR3027787T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE168373T1 (de) | 1998-08-15 |
| CN1097749A (zh) | 1995-01-25 |
| JP3452088B2 (ja) | 2003-09-29 |
| DE69411625T2 (de) | 1998-11-05 |
| ES2118283T3 (es) | 1998-09-16 |
| JPH06329652A (ja) | 1994-11-29 |
| CZ112994A3 (en) | 1994-11-16 |
| HU9401415D0 (en) | 1994-08-29 |
| DE69411625D1 (de) | 1998-08-20 |
| RU94015838A (ru) | 1997-02-20 |
| NO941662L (no) | 1994-11-07 |
| FI942049A0 (fi) | 1994-05-04 |
| NO941662D0 (no) | 1994-05-05 |
| EP0623607A1 (en) | 1994-11-09 |
| EP0623607B1 (en) | 1998-07-15 |
| IL109526A0 (en) | 1994-08-26 |
| AU6055894A (en) | 1994-11-10 |
| GR3027787T3 (en) | 1998-11-30 |
| DK0623607T3 (da) | 1999-04-19 |
| FI942049A (fi) | 1994-11-07 |
| HUT67847A (en) | 1995-05-29 |
| GB9309324D0 (en) | 1993-06-16 |
| RU2125564C1 (ru) | 1999-01-27 |
| NZ260445A (en) | 1995-08-28 |
| CA2122788A1 (en) | 1994-11-07 |
| US5504213A (en) | 1996-04-02 |
| SK53194A3 (en) | 1995-02-08 |
| AU678814B2 (en) | 1997-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3027787T3 (en) | Benzofuranyl-and-thiophenyl-alkanecarboxyclic acid derivatives. | |
| AU603525B2 (en) | Tetrazole intermediates to antihypertensive compounds | |
| AU8979191A (en) | 3,7-disubstituted indole derivatives | |
| DE59208974D1 (de) | Neue pyrazinderivative, ihre herstellung und verwendung | |
| AU1058492A (en) | Improvements in or relating to organic compounds | |
| GR3033350T3 (en) | Use of Beta-aminopropionic acid derivatives as fungicides | |
| EP0712844A4 (en) | NOVEL CARBOXYLIC ACID COMPOUND WITH FUSED CORE OR SALT THEREOF, AND ITS USE IN MEDICINE | |
| IL111184A (en) | Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin | |
| DK0625520T3 (da) | Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet | |
| HUT75124A (en) | Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity | |
| FI960588A0 (fi) | Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä | |
| AU6797590A (en) | Improvements in or relating to organic compounds | |
| GR3015002T3 (en) | 1,4-Dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents. |